Singapore grants interim approval for Novavax’s COVID-19 vaccine
SINGAPORE — Singapore’s Health Sciences Authority (HSA) said on Monday it has granted an interim authorization for Novavax’s COVID-19 vaccine.
The first batch of the Nuvaxovid vaccine is expected to arrive in Singapore in the next few months, the HSA said.
RELATED STORIES
Germans pin hopes on Novavax moving the needle among anti-vaxxers
FEATURED STORIES
South Korea authorizes use of Novavax COVID-19 vaccine
Novavax says COVID vaccine triggers immune response to Omicron variant
Novavax says COVID-19 shot 80% effective in adolescent study
Novavax COVID-19 vaccine gets emergency use approval in PH